pharmaphorum May 13, 2022
Jonah Comstock

When it comes to enthusiasm about digital innovation, pharma seems to be more adept at talking the talk than walking the walk, as it were. That’s according to recent survey data from digital agency Graphite. Working with Reuters Events, the agency surveyed 450 healthcare executives, 85% of whom worked in pharma.

A full 92% of the survey respondents agreed with the statement “Pharma-sponsored digital products can add value to the healthcare provider and patient by supporting the overall customer experience”, with 57.3% strongly agreeing and 33.8% somewhat agreeing.

But when asked whether their digital product launches regularly succeed, only four percent of respondents answered yes.

“To some extent, this boils down to a lack of understanding of digital best practice...

Today's Sponsors

SalesSparx
Canton & Company
Curation Health

Today's Sponsors

Amwell
Oliver Wyman

Today's Sponsor

Canton & Company

 
Topics: Digital Health, Pharma, Pharma / Biotech, Survey / Study, Technology, Trends
The healthcare technology behind electronic drug delivery
FDA Webinar Provides New Insights on Use of Digital Health Technologies in Clinical Trials
FDA Addresses the Role of Digital Health Technology in Clinical Trials
The impact of drug innovation on disability and medical care
New FDA Draft Guidance on Use of Digital Health Technologies in Clinical Trials